Whitehawk Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Morristown, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Whitehawk Therapeutics, Inc. has filed 652 SEC EDGAR filings since 01 Feb 2008

SEC filing history

Showing 326-350 of 638 matching filings.

Per page
25
Current page
14
8-K File 001-38560

8-K

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38560

8-K

Filing date
26 Jul 2021
Reporting date
22 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83932

AERPIO PHARMACEUTICALS, INC.

Filing date
12 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 001-38560

DEFM14A

Filing date
08 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2021
Reporting date
17 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-38560

PREM14A

Filing date
21 Jun 2021
Reporting date
21 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38560

DEFA14A

Filing date
09 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38560

DEF 14A

Filing date
09 Jun 2021
Reporting date
22 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38560

DEFA14A

Filing date
04 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38560

8-K

Filing date
04 Jun 2021
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-83932

AERPIO PHARMACEUTICALS, INC.

Filing date
04 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83932

SCHEDULE 13G

Filing date
26 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38560

DEFA14A

Filing date
20 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38560

8-K

Filing date
20 May 2021
Reporting date
19 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38560

8-K

Filing date
17 May 2021
Reporting date
17 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38560

8-K

Filing date
17 May 2021
Reporting date
16 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38560

8-K

Filing date
17 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .